Venus Remedies Limited (BOM:526953)

Venus Remedies Statistics

Total Valuation

Venus Remedies has a market cap or net worth of INR 15.55 billion. The enterprise value is 14.64 billion.

Market Cap	15.55B
Enterprise Value	14.64B

Important Dates

The last earnings date was Tuesday, May 26, 2026.

Earnings Date	May 26, 2026
Ex-Dividend Date	n/a

Share Statistics

Venus Remedies has 13.37 million shares outstanding. The number of shares has increased by 0.00% in one year.

Current Share Class	13.37M
Shares Outstanding	13.37M
Shares Change (YoY)	+0.00%
Shares Change (QoQ)	+0.01%
Owned by Insiders (%)	30.05%
Owned by Institutions (%)	1.13%
Float	6.37M

Valuation Ratios

The trailing PE ratio is 15.13.

PE Ratio	15.13
Forward PE	n/a
PS Ratio	1.99
PB Ratio	2.34
P/TBV Ratio	2.73
P/FCF Ratio	13.17
P/OCF Ratio	9.99
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.16, with an EV/FCF ratio of 12.40.

EV / Earnings	14.25
EV / Sales	1.87
EV / EBITDA	9.16
EV / EBIT	10.91
EV / FCF	12.40

Financial Position

The company has a current ratio of 2.44, with a Debt / Equity ratio of 0.02.

Current Ratio	2.44
Quick Ratio	1.33
Debt / Equity	0.02
Debt / EBITDA	0.08
Debt / FCF	0.11
Interest Coverage	3,354.75

Financial Efficiency

Return on equity (ROE) is 16.78% and return on invested capital (ROIC) is 21.74%.

Return on Equity (ROE)	16.78%
Return on Assets (ROA)	10.69%
Return on Invested Capital (ROIC)	21.74%
Return on Capital Employed (ROCE)	19.39%
Weighted Average Cost of Capital (WACC)	5.04%
Revenue Per Employee	6.03M
Profits Per Employee	791,834
Employee Count	1,298
Asset Turnover	1.00
Inventory Turnover	3.37

Taxes

In the past 12 months, Venus Remedies has paid 313.70 million in taxes.

Income Tax	313.70M
Effective Tax Rate	23.38%

Stock Price Statistics

The stock price has increased by +220.39% in the last 52 weeks. The beta is 0.15, so Venus Remedies's price volatility has been lower than the market average.

Beta (5Y)	0.15
52-Week Price Change	+220.39%
50-Day Moving Average	957.17
200-Day Moving Average	698.25
Relative Strength Index (RSI)	70.30
Average Volume (20 Days)	6,424

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Venus Remedies had revenue of INR 7.82 billion and earned 1.03 billion in profits. Earnings per share was 76.89.

Revenue	7.82B
Gross Profit	3.95B
Operating Income	1.34B
Pretax Income	1.34B
Net Income	1.03B
EBITDA	1.60B
EBIT	1.34B
Earnings Per Share (EPS)	76.89

Balance Sheet

The company has 1.03 billion in cash and 124.10 million in debt, with a net cash position of 910.00 million or 68.08 per share.

Cash & Cash Equivalents	1.03B
Total Debt	124.10M
Net Cash	910.00M
Net Cash Per Share	68.08
Equity (Book Value)	6.64B
Book Value Per Share	496.59
Working Capital	2.33B

Cash Flow

In the last 12 months, operating cash flow was 1.56 billion and capital expenditures -376.50 million, giving a free cash flow of 1.18 billion.

Operating Cash Flow	1.56B
Capital Expenditures	-376.50M
Depreciation & Amortization	256.70M
Net Borrowing	-25.30M
Free Cash Flow	1.18B
FCF Per Share	88.37

Margins

Gross margin is 50.49%, with operating and profit margins of 17.16% and 13.14%.

Gross Margin	50.49%
Operating Margin	17.16%
Pretax Margin	17.15%
Profit Margin	13.14%
EBITDA Margin	20.44%
EBIT Margin	17.16%
FCF Margin	15.10%

Dividends & Yields

Venus Remedies does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.00%
Shareholder Yield	-0.00%
Earnings Yield	6.61%
FCF Yield	7.59%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	6